Loading...
XHKG1112
Market cap737mUSD
Dec 23, Last price  
8.89HKD
1D
-1.00%
1Q
5.83%
Jan 2017
-62.88%
IPO
-19.03%
Name

Health And Happines(H&H)Intrntnl Hds Ltd

Chart & Performance

D1W1MN
XHKG:1112 chart
P/E
9.24
P/S
0.39
EPS
0.90
Div Yield, %
8.29%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
6.57%
Revenues
13.93b
+9.01%
558,969,0001,233,560,0002,189,034,0003,381,901,0004,561,299,0004,731,563,0004,818,561,0006,505,616,0008,095,345,00010,132,498,00010,925,217,00011,194,679,00011,547,825,00012,775,914,00013,926,470,000
Net income
582m
-4.89%
108,317,000265,683,000527,351,000743,106,000820,715,000806,786,000251,461,000954,396,000932,846,000843,148,0001,005,049,0001,136,694,000508,484,000611,783,000581,845,000
CFO
1.10b
-25.35%
109,798,000381,012,000516,212,000947,182,000660,473,000972,172,000365,732,0001,543,193,0001,950,814,0001,697,212,0001,439,243,0001,532,552,0001,890,080,0001,469,313,0001,096,819,000
Dividend
Sep 10, 20240.3 HKD/sh
Earnings
Mar 24, 2025

Profile

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
URL
http://www.hh.global
IPO date
Dec 17, 2010
Employees
3,372
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
13,926,470
9.01%
12,775,914
10.63%
11,547,825
3.15%
Cost of revenue
12,094,124
11,193,530
10,111,387
Unusual Expense (Income)
NOPBT
1,832,346
1,582,384
1,436,438
NOPBT Margin
13.16%
12.39%
12.44%
Operating Taxes
351,757
419,148
341,729
Tax Rate
19.20%
26.49%
23.79%
NOPAT
1,480,589
1,163,236
1,094,709
Net income
581,845
-4.89%
611,783
20.32%
508,484
-55.27%
Dividends
(474,529)
(233,623)
(407,518)
Dividend yield
6.04%
2.18%
5.22%
Proceeds from repurchase of equity
(118,677)
68,245
BB yield
1.11%
-0.87%
Debt
Debt current
4,759,559
1,008,613
3,169,022
Long-term debt
4,570,052
8,761,965
6,411,425
Deferred revenue
Other long-term liabilities
842,563
189,036
439,653
Net debt
7,543,692
7,045,537
6,704,685
Cash flow
Cash from operating activities
1,096,819
1,469,313
1,890,080
CAPEX
(58,067)
(102,493)
(106,594)
Cash from investing activities
(52,071)
(104,876)
(4,010,586)
Cash from financing activities
(1,994,607)
(1,489,801)
2,768,391
FCF
1,371,360
1,221,429
1,108,901
Balance
Cash
1,448,611
2,303,660
2,400,070
Long term investments
337,308
421,381
475,692
Excess cash
1,089,596
2,086,245
2,298,371
Stockholders' equity
5,573,146
7,082,409
6,678,876
Invested Capital
15,270,744
13,594,648
13,172,557
ROIC
10.26%
8.69%
9.10%
ROCE
11.20%
9.58%
8.81%
EV
Common stock shares outstanding
644,867
644,323
645,672
Price
12.18
-26.89%
16.66
37.91%
12.08
-59.33%
Market cap
7,854,479
-26.83%
10,734,416
37.63%
7,799,722
-59.38%
EV
15,398,171
19,442,587
16,014,179
EBITDA
2,134,599
1,893,667
1,741,913
EV/EBITDA
7.21
10.27
9.19
Interest
807,605
530,292
263,739
Interest/NOPBT
44.07%
33.51%
18.36%